NEWS

RVAC Medicines Appoints Mohamed ElSayed, Ph.D., as Chief Technology Officer

RVAC Medicines Raises US$140 Million to Expand R&D and Manufacturing Capacity

RVAC Medicines to Present at Vaccine Summit Boston 2022

mRNA platform company RVAC Medicines held the groundbreaking ceremony in Minhang, Shanghai

中国与全球技术携手创新又一里程碑：康桥资本自主孵化的峨威生物闵行工厂开工